BREAKOUT STOCK ALERT UPDATE
INO - Inovio Pharmaceuticals, Inc. - Common Stock
Initial Alert Price: $9.69
Price High: $19
% Gains/Losses: 96.08%
(+74.02% More Than Expected)
Potential Stop Loss: $18.05
INO hit $19.74 in today's premarket session after the company announced that it was awarded the US Patent for their oral device and use of thereof providing us with a 103.72% Return on Our Initial Investment from Jan. 19th, 2021. The stock consolidated and found support on the $13.83 Price Level before bouncing back and closing around the $14.87 Prices Levels. When the stock dropped from the $19.00 Price Range, we saw large sells volume spikes but it seemed to lower as the trading session continue and we have not seen too much sells volume to close this trade out yet. We are currently looking for signals for a continue moved to the upside moving forward and will be watching this stock going into tomorrow's trading sessions. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Initial Alert Price: $9.69
Price High: $19
% Gains/Losses: 96.08%
(+74.02% More Than Expected)
Potential Stop Loss: $18.05
INO hit $19.74 in today's premarket session after the company announced that it was awarded the US Patent for their oral device and use of thereof providing us with a 103.72% Return on Our Initial Investment from Jan. 19th, 2021. The stock consolidated and found support on the $13.83 Price Level before bouncing back and closing around the $14.87 Prices Levels. When the stock dropped from the $19.00 Price Range, we saw large sells volume spikes but it seemed to lower as the trading session continue and we have not seen too much sells volume to close this trade out yet. We are currently looking for signals for a continue moved to the upside moving forward and will be watching this stock going into tomorrow's trading sessions. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。
